Intratumoral expression of JAML on NK cells is controlled by tumor microenvironment and MHC class I interaction
Labuz, D.; Angenendt, S.; Marek, N.; Bremser, J.; Braddish, D. M.; Nyman, L.; Fischbach, J.; Keim, L.; Hyland, A.; Bento, C.; Michie, R.; Lane, R. M.; Passacatini, C.; Pei, S.; Pan, Y.; Karlsson, M. C. I.; Pumpe, A.; Oppelt, A.-S.; Wilhelm, M.; Tibbitt, C.; Chan, S.; Ribacke, U.; Saldan, A.; Kärre, K.; Johansson, M. H.; Wagner, A. K.; Coquet, J.; Chambers, B. J.
Show abstract
Junctional adhesion molecule-like (JAML) is an adhesion molecule known to promote T cell activation and T cell-mediated tumor rejection. In the current study, we show that JAML expression is enriched on mouse intratumoral NK cells compared with splenic NK cells. JAML+ NK cells were associated with tissue residency and co-expressed the immune checkpoints PD-1 and LAG3. JAML expression could be induced on splenic NK cells by IL-2 and further enhanced by IL-21. JAML levels were inversely correlated with inhibitory signaling, as NK cells expressing self-recognizing Ly49 receptors had reduced JAML expression, suggesting regulation of JAML expression by MHC class I molecules. Interaction with the JAML ligand CXADR also reduced JAML surface expression, indicating that tumor-mediated membrane stripping may represent a mechanism of immunoediting. Although JAML RNA transcripts were detectable in human NK cells, JAML protein was found only intracellularly. Together, these findings identify the JAML-CXADR interaction as a potential regulatory pathway in NK cell-mediated killing of tumors.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.